Znanstveni rad - Prikaz slučaja
Nintedanib treatment for bleomycin-induced lung injury - First report
Respiratory Medicine Case Reports, 46 (2023); 101921. https://doi.org/10.1016/j.rmcr.2023.101921

Rnjak, Dina; Batarilo Hađar, Martina; Pelicarić, Dubravka; Vukić, Tea; Janković Makek, Mateja; Samaržija, Miroslav; Hećimović, Ana

Citirajte ovaj rad

Rnjak, D., Batarilo Hađar, M., Pelicarić, D., Vukić, T., Janković Makek, M., Samaržija, M. i Hećimović, A. (2023). Nintedanib treatment for bleomycin-induced lung injury - First report. Respiratory Medicine Case Reports, 46.. doi: 10.1016/j.rmcr.2023.101921

Rnjak, Dina, et al. "Nintedanib treatment for bleomycin-induced lung injury - First report." Respiratory Medicine Case Reports, vol. 46, 2023. https://doi.org/10.1016/j.rmcr.2023.101921

Rnjak, Dina, Martina Batarilo Hađar, Dubravka Pelicarić, Tea Vukić, Mateja Janković Makek, Miroslav Samaržija i Ana Hećimović. "Nintedanib treatment for bleomycin-induced lung injury - First report." Respiratory Medicine Case Reports 46 (2023). https://doi.org/10.1016/j.rmcr.2023.101921

Rnjak, D., et al. (2023) 'Nintedanib treatment for bleomycin-induced lung injury - First report', Respiratory Medicine Case Reports, 46. doi: 10.1016/j.rmcr.2023.101921

Rnjak D, Batarilo Hađar M, Pelicarić D, Vukić T, Janković Makek M, Samaržija M, i sur.. Nintedanib treatment for bleomycin-induced lung injury - First report. Respiratory Medicine Case Reports [Internet]. 27.09.2023. [pristupljeno 17.06.2024.];46. doi: 10.1016/j.rmcr.2023.101921

D. Rnjak, et al., "Nintedanib treatment for bleomycin-induced lung injury - First report", Respiratory Medicine Case Reports, vol. 46, Rujan 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:407335. [Citirano: 17.06.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.